000 to ALS Biopharma.

ALS Biopharma receives ADDF grant to develop therapeutics against Alzheimer’s disease The Alzheimer’s Medication Discovery Foundation announced today that it has awarded a grant of $195,000 to ALS Biopharma, LLC to build up therapeutics directed at clearing toxic proteins implicated in Alzheimer’s disease http://vardenafiluk.com .This program will identify and develop small-molecule brain-penetrant inducers of heat shock protein 70 . Allen Reitz, CEO of ALS Biopharma. ‘We are excited to aid ALS Biopharma’s innovative program in this target region,’ stated Howard Fillit, MD, Executive Director of the ADDF.